Cancer-specific alterations in nuclear matrix proteins determined by multi-omics analyses of ductal carcinoma in situ
These genes should form the basis of, or contribute to, a molecular diagnostic panel that could identify DCIS lesions likely to be indolent and therefore not requiring aggressive treatment.
Authors
- Abdullah S. Alhamed (ORCID: https://orcid.org/0000-0001-8933-3490)
- C. Simmons (ORCID: https://orcid.org/0000-0002-1300-1307)
- Stephen G. Grant (ORCID: https://orcid.org/0000-0002-9236-0913)
- Miranda J. Sarachine Falso
- Billy W. Day (ORCID: https://orcid.org/0000-0001-6208-9950)
- Jean J. Latimer (ORCID: https://orcid.org/0000-0002-4882-5170)
- Ali F. Almutairy (ORCID: https://orcid.org/0009-0007-7954-4893)
Institutions
- Qassim University (SA)
- University of Pittsburgh (US)
- Nova Southeastern University (US)
- King Saud University (SA)
- AutoNation (United States) (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-05
- DOI
- https://doi.org/10.3389/fonc.2024.1406946
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- National Institutes of Health